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Abstract
Background: Endometriosis has been shown to be associated with second- to third-trimester pregnancy complications
such as preterm birth and placenta previa, but the evidence is inconsistent. We hypothesized that endometriosis severity
might affect these inconsistent results. Therefore we aimed to conduct a retrospective cohort study to elucidate whether
endometriosis severity is associated with the incidence rates of adverse pregnancy outcomes.
Methods: The patients who achieved singleton pregnancy by assisted reproductive technology (ART) in our
facility between March 2000 and December 2014 (N = 631) were included in this analysis. Among them, 92
women demonstrated surgically proven endometriosis, and 512 women were shown to not have endometriosis as a
complication. Among the 92 cases of endometriosis, 10 were classified as revised American Society for Reproductive
Medicine (rASRM) stage I and II, 31 cases were rASRM stage III, and 43 cases were rASRM stage IV; in 8 cases, the rASRM
stage was unavailable. Logistic regression analysis was performed to calculate odds ratios (OR) and 95 % confidence
interval (CI) for the rates of preterm birth, placenta previa, and small for gestational age. OR were adjusted by age,
parity and the number of transferred embryos.
Results: First we confirmed the frequency of preterm birth and placenta previa were significantly increased in women
with endometriosis (preterm birth OR, 2.08; 95 % CI, 1.07–3.89, placenta previa OR, 15.1; 95 % CI, 4.40–61.7), while the
frequency of small for gestational age was not. Moreover, we found the frequencies of preterm birth and placenta
previa were significantly increased in women with rASRM stage IV endometriosis compared to other two groups:
women with rASRM stage I-III endometriosis (preterm birth OR, 7.40; 95 % CI, 1.83–50.3; placenta previa OR, 11.0;
95 % CI, 1.75–216.5) and women without endometriosis (preterm birth adjusted OR, 4.11; 95 % CI, 1.88–8.55;
placenta previa adjusted OR, 39.8; 95 % CI, 10.1–189.1). There were no significant difference between women
with rASRM I-III endometriosis and women without endometriosis.
Conclusions: We found that the frequencies of preterm birth and placenta previa were significantly increased in
women with endometriosis, and the severity of endometriosis might have an adverse impact on ART pregnancy.
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Background
Endometriosis is defined as an abnormal development of
endometrial tissue outside the uterus. This condition
causes chronic inflammation in the pelvis of reproductive-
aged women. Estrogen is associated with the pathogenesis
of endometriosis because the symptoms related to endo-
metriosis resolve soon after the cessation of menstruation.
The chronic inflammation results in the generation of
ovarian endometrioma and the formation of adhesions in
the reproductive organs; thus, it is well known that this
disease is associated with infertility [1, 2]. In addition, the
T helper (Th)1/Th2 balance has been established to be
disrupted in patients with endometriosis [3]. Moreover,
endometriosis might affect the expression patterns of pro-
gesterone receptors (PR) A and PR B [4].
Recently, endometriosis has been shown to be asso-
ciated with second- to third-trimester pregnancy com-
plications, such as preterm birth, preeclampsia, small
for gestational age (SGA) and placenta previa [3–6].
However, several investigators have reported that the
association between endometriosis and pregnancy
complications is questionable [7–9], and the associ-
ation remains under debate [10, 11]. Some reports
have suggested that not endometriosis itself but ovar-
ian endometrioma and rectovaginal endometriosis
might be associated with adverse pregnancy outcomes.
A retrospective cohort study suggested that ovarian
endometrioma was associated with preterm birth, but
endometriosis without ovarian endometrioma was not
associated with preterm birth in assisted reproductive
technology (ART) pregnancy [12]. An association be-
tween placenta previa and rectovaginal endometriosis
has been previously reported [7]. However multivariate
analysis was not performed in this study, and evidence
is limited. From these observations, it is still difficult
to conclude what types of endometriosis increases the
risk for pregnancy complications.
In general, minimal and mild endometriosis corres-
pond to peritoneal disease, while moderate endometri-
osis corresponds to one ovarian endometrioma > 3 cm,
and severe endometriosis corresponds to bilateral
endometriomas and/or complete pouch of Douglas
obliteration, according to the revised American Soci-
ety for Reproductive Medicine (rASRM) scoring sys-
tem, which is widely used to evaluate and stage
endometriosis severity [1]. To take into account the
association between ovarian endometrioma or rectova-
ginal endometriosis and the increased rates of preterm
birth and placenta previa, we hypothesized that
rASRM stage might affect the incidence rates of these
pregnancy complications. Therefore, the aim of this
study was to evaluate the association between endo-
metriosis and pregnancy complications as well as to
investigate the influence of endometriosis severity on




The demographic data of each case were recorded in a
medical record of our hospital. These data included the
patient’s age, parity, past medical history including surgi-
cal records, suspected causes of infertility, the number
of transferred embryos and pregnancy outcomes. Sample
collection was performed by extracting data from these
records. According to the database, 631 singleton babies
were born as a result of ART performed in our hospital
between March 2000 and December 2014.
Diagnosis and surgical treatment of endometriosis
Laparoscopy is the most reliable procedure for diagnos-
ing and classifying endometriosis [1]. Therefore, current
data were based on laparoscopic findings to accurately
evaluate the risks of pregnancy with endometriosis. In
each case, therapeutic procedures, such as adhesiot-
omy, coagulation, and cystectomy, were performed by
trained personnel at our hospital to treat the detected
endometriosis.
The women who had laparoscopically diagnosed endo-
metriosis were categorized as “endometriosis diagnosed
by laparoscopy” (n = 92). The women who were sus-
pected to have endometriosis by transvaginal ultrasound
or medical history but did not undergo laparoscopy were
categorized as having “suspected endometriosis” and
were excluded from this study (n = 20). The other
women who were not suspected to have endometriosis
by transvaginal ultrasound or in whom the presence of
endometriosis was denied by laparoscopy were catego-
rized as “denied presence of endometriosis” (n = 512).
The women classified as “endometriosis diagnosed by
laparoscopy” and “denied presence of endometriosis”
were included in this study. Seven women were excluded
because of complications before pregnancy; four suffered
endometrial cancer, one was diagnosed with cervical
cancer in early pregnancy, and two were recovering from
conization. We used the rASRM scoring system to
evaluate the severity of endometriosis because this is a
widely accepted scoring system [1]. Of the 92 cases of
laparoscopically diagnosed endometriosis, 10 cases were
rASRM stage I and II, 31 were rASRM stage III, and 43
were rASRM stage IV; in 8 cases, the rASRM stage was
unavailable. Sample collection criteria was summarized
in Fig. 1.
Complication outcomes during pregnancy
We analyzed following adverse pregnancy outcomes:
preterm birth, placenta previa, and SGA. The defini-
tions used in this study for the diagnosis of these
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complications was as follows. Preterm birth was defined
as delivery before 37 complete weeks of gestation. Pla-
centa previa was defined as the condition in which the
placenta at least partially covered the internal ostium.
SGA defined as an infant weight less than the 10th per-
centile for the gestational age.
Statistical analysis
All statistical analyses were performed using JMP PRO
11 software (SAS Institute Inc., Cary, NC, USA). Fisher’s
exact test was used to calculate p values for the com-
parison of maternal characteristics with or without
endometriosis. Logistic regression analysis was used to
calculate the adjusted odds ratios (AORs) and 95 %
confidence intervals (CIs) in the analysis of adverse
pregnancy outcomes. Odds ratios were adjusted by age,
parity and the number of transferred embryos.
Results
Characteristics of the patients included in this study
The preconceptional characteristics of the patients in-
cluded in this study are summarized in Table 1. There
were no significant differences in age, previous parity or
the number of embryos transferred between the women
with or without endometriosis.
Preterm birth and placenta previa were increased in
women with endometriosis
The risks of preterm birth, placenta previa, and SGA in
ART pregnancy with or without endometriosis are
shown in Table 2. The risks of preterm birth and pla-
centa previa were significantly increased in the pregnant
women with endometriosis (preterm birth AOR, 2.08;
95 % CI, 1.07–3.89, placenta previa AOR, 15.1; 95 % CI,
4.40–61.7). No significant difference was found in the
risk of SGA.
Preterm birth and placenta previa were increased in
women with rASRM stage IV but not stage I-III
endometriosis
The risks of adverse pregnancy outcomes were com-
pared among the following three groups: the women
with rASRM stage I–III endometriosis, the women with
rASRM stage IV endometriosis and the women without
endometriosis. The risks of preterm birth and placenta
previa were significantly increased in the women with
rASRM stage IV endometriosis compared to the women
with rASRM stage I-III endometriosis (preterm birth
AOR, 7.40; 95 % CI, 1.83–50.3; placenta previa AOR,
11.0; 95 % CI, 1.75–216.5) and to the women without
endometriosis (preterm birth AOR, 4.11; 95 % CI, 1.88–
8.55; placenta previa AOR, 39.8; 95 % CI, 10.1–189.1).
However, the risks of these adverse pregnancy outcomes
Fig. 1 Flowchart of sample collection criteria. Among 631 cases, 7 cases were excluded because of the following complications: past medical
history for the treatment of endometrial cancer (n = 4), cervical cancer diagnosed in early pregnancy (n = 1), and previous conization (n = 2). Of
the remaining 624 cases, laparoscopically diagnosed endometriosis was present in 92 cases, which were classified as “endometriosis diagnosed
by laparoscopy.” Twenty cases were excluded from this study because endometriosis was suspected but not diagnosed by laparoscopy.
The other 512 cases were classified as “denied presence of endometriosis.” Among the 92 cases of “endometriosis diagnosed by laparoscopy,”
10 cases were classified as rASRM stage I or II, 31 cases were rASRM stage III, and 43 cases were rASRM stage IV. In eight cases, the rASRM stage was
unavailable. ART: assisted reproductive technology, rASRM: revised American Society for Reproductive Medicine
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were not increased in the women with rASRM stage I-
III endometriosis compared to the women without
endometriosis. No significant differences were found in
the risk of SGA between any two groups (Table 3).
Discussion
From this study, we found that ART pregnancy compli-
cated with endometriosis carries a high risk of preterm
birth and placenta previa, especially in women with
rASRM stage IV endometriosis. The incidence rates of
preterm birth and placenta previa in rASRM stage IV
(27.9 and 17.1 %, respectively) were surprisingly high
compared to the general incidence rates reported in
Japan (5–6 and 0.5–0.7 %, respectively) [12, 13]. These
data suggest that there is a strong association between
severe endometriosis and these pregnancy complica-
tions. To our knowledge, this is the first report to sug-
gest the correlation of endometriosis severity and
adverse outcomes in the second and third trimester of
pregnancy.
This study was only included ART pregnancies to
avoid the influence of conception methods. ART preg-
nancy is known to carry a high risk of adverse pregnancy
outcomes, such as preterm birth and placenta previa,
compared with natural conception [14, 15]; however, the
underlying mechanism of the increased risk for adverse
outcomes in ART pregnancy remains unclear. One re-
port suggests that not only the ART procedure itself but
also underlying causes of infertility might be associated
with adverse pregnancy outcomes in ART pregnancy
[16]. According to this point of view, we could also con-
clude that endometriosis, one of the most prevalent dis-
eases causing infertility in women, might be a crucial
factor of increased adverse outcomes in ART pregnancy.
On the other hand, rASRM stage I-III endometriosis
followed by therapeutic laparoscopic procedures might
not be associated with second- and third- trimester
pregnancy complications. While the sample size of
rASRM stage I-III endometriosis in this study was in-
sufficient to completely deny the association between
minimal to moderate endometriosis and pregnancy
complications, at least strong associations were not rec-
ognized in this study. These results seemed to be in-
consistent with those of past studies, which suggested
an association of endometrioma with preterm birth
[12]; however, we have to consider that no endometrio-
mas were present at the time of conception in most
cases included in this study because of therapeutic pro-
cedures performed for endometriosis. In that context,
our results are consistent with those of past studies.
These results are also interesting in terms of the
mechanisms underlying the increased risks of pregnancy
complications in women with endometriosis. In most
cases in this study, ovarian endometriomas were almost
completely removed by laparoscopic surgery, and appar-
ent recurrences were not observed. However, strong ad-
hesions mainly recognized in rASRM stage IV cases
were not completely removed. We speculate that these
remaining adhesions and inflammation in the rectovagi-
nal region might be the main cause of the increased risks
of preterm birth and placenta previa, as previously sug-
gested [7].
This study also had some limitations. Adenomyosis is
a disease characterized by the presence of endometrial
tissue deep within the uterine myometrium [17], and an
association of adenomyosis with preterm birth has been
previously reported [16, 17]. Therefore, adenomyosis
might have influenced the increased incidence rate of
preterm birth in this study. On the other hand, to the
best of our knowledge, no reports have suggested an as-
sociation between adenomyosis and placenta previa. Fur-
ther research is needed to elucidate the influence of
adenomyosis on the increased risk of preterm birth in
women with endometriosis.







Age (year, mean) 34.7 35.4 0.078
Previous parity 0.29
0 78 (84.8 %) 396 (77.6 %)
1 14 (15.2 %) 113 (22.2 %)
2 0 1 (0.2 %)
No. of ET for conception 0.788
1 55 (59.8 %) 292 (57.0 %)
2 28 (30.4 %) 151 (29.5 %)
3 9 (9.8 %) 68 (13.3 %)
4 0 1 (0.2 %)
Note: ART assisted reproductive technology; ET embryos transferred
Table 2 Complications during pregnancy in women with or without endometriosis
ART with endometriosis ART without endometriosis Odds ratio (95 % Cl)a P value
Preterm birth 15 (16.5 %) 43 (8.5 %) 2.08 (1.07–3.89) 0.032
Placenta previa 8 (9.1 %) 4 (0.8 %) 15.1 (4.40–61.7) < 0.001
SGA 11 (14.1 %) 52 (10.3 %) 1.43 (0.68–2.81) 0.332
SGA small for gestational age, CI confidence interval
aAdjusted by age, parity, and the number of transferred embryos
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Conclusion
We found that ART pregnancies complicated with
endometriosis, especially laparoscopically diagnosed se-
vere endometriosis, and carried a high risk for preterm
birth and placenta previa. These findings are clinically
relevant to obstetricians for distinguishing high- and
low-risk pregnancies.
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